On April 10, 2024, NeuroSense Therapeutics Ltd. completed a securities offering, selling 1,732,000 shares at $1.50 each and 1,248,000 pre-funded warrants for a total of about $4.47 million. This includes a concurrent private placement of 2,980,000 ordinary warrants at an exercise price of $1.50, subject to certain conditions.